Abstract
Abstract
Background
Pipemidic acid, like other quinolones, is susceptible against different organisms in vitro, and it was proved to be a preferred choice for certain indications. Previous studies reveal that concurrent administration of essential and trace elements with quinolones decreases gastrointestinal absorption, causing therapeutic failure. To study the probable interaction of pipemidic acid with essential and trace elements present in the human body, pipemidic acid has been reacted with magnesium, calcium, chromium, manganese, iron, cobalt, nickel, copper, zinc, and cadmium, the complexes formed.
Results
The compounds were characterized by the melting point, conductance studies, IR, UV, 1H-NMR, CHN, and atomic absorption analysis.
Conclusion
The results suggested oxygen atoms present at carbonyl and carboxylic group render the bidentate6 property to the pipemidic acid. The antimicrobial activity of the compounds was determined by the disk diffusion method, and both standard and complexes show no antibacterial activity against the clinical isolates.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Budavari S. (2001) The Merck Index. Merck & Co. Inc. Germany. p. 403, 1200, 1266
2. Mroz E, Jankowski S, Bartelmus J, Grzybek-Hryncewicz K, Ruczkowska J, Starek J, Boratynska M (1993) Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections. Med Dosw Mikrobiol. 45(1):115–118
3. Muytjens HL, Veldhuizen GL, Welling GW, Ros-van de Repe J, Boerema HB, Waaij D (1983) Selective decontamination of the digestive tract by pipemidic acid. Antimicrob Agents Chemother. 24(6):902–904. https://doi.org/10.1128/AAC.24.6.902
4. Paula C, Alves PR, Bravo C, Antunes AMM, André V (2020) Bioactivity of isostructural hydrogen bonding frameworks built from pipemidic acid metal complexes. Molecules 25:2374. https://doi.org/10.3390/molecules25102374
5. Harder S (1989) Ciprofloxacin caffeine, a drug interaction established using in vivo and in vitro investigations. Am J Med. 33:474–478